Breaking AI & Tech News Analyzed

The Final Hours: 50% Off Second Pass to TechCrunch Disrupt 2026 Time is running out to take advantage of the 50% off offer for a second pass to TechCrunch Disrupt 2026. Today, May 8th, is the last day to register and secure your spot at the premier tech conference in San Francisco. Unlock the Full Potential of Disrupt 2026 Attending Disrupt with a partner, co-founder, or colleague can significantly enhance your experience. You'll gain more insights, compare notes in real-time, and make informed decisions. The 50% off offer for a second pass is a unique opportunity to bring someone along and maximize your time at the conference. What You'll Gain at Disrupt 2026 Access to over 250 sessions, covering real-world playbooks and industry trends Opportunities to connect with key players, investors, and innovators Enhanced networking capabilities with a second pass The Cost of Waiting Missing this offer means more than just paying a higher price. It means attending the conference with a limited perspective, choosing between sessions, and processing information without the benefit of real-time discussion and feedback. Act Now and Save Don't miss your chance to save up to $410 on your pass and get 50% off a second pass. Register now and secure your spot at Disrupt 2026. The offer ends tonight at 11:59 p.m. PT.

The Limited Time Offer Only two days are left to secure a spot at TechCrunch Disrupt 2026 with a 50% discount on a second pass. This offer is available for all types of passes, including Founder, Investor, Attendee, Non-profit, and Expo+. The Benefits of Attending Disrupt 2026 Attendees will have access to high-impact programming, unparalleled networking opportunities, and real-time insights from industry leaders. The event features a range of sessions, including the Startup Battlefield 200, where founders pitch live in front of seasoned VC judges and a global audience. The Importance of Bringing a Second Person Bringing a co-founder, operator, or partner can accelerate clarity and decision-making. Attendees can compare interpretations in real-time, challenge assumptions, and make better decisions while the context is still fresh. Pass Options Founder Pass: Access investor meetings, Deal Flow Café, curated networking, and programming on scaling, fundraising, and growth. Investor Pass: Connect directly with founders, access curated deal flow, and participate in investor-focused sessions and networking. Attendee Pass: Full access to stages, breakouts, roundtables, and networking to understand what's working across the ecosystem. Non-profit Pass: Explore how emerging tech applies to mission-driven organizations and connect with builders and partners. Expo+ Pass: Focused access to the Expo Hall, breakouts, and networking. Don't Miss Out The offer ends on May 8 at 11:59 p.m. PT. Register now to secure your spot and bring someone with you at 50% off.

The Rise of Moonshot AI Chinese AI companies are making waves in the industry, despite not having the same level of funding as their Western counterparts. Moonshot AI, a Beijing-based AI lab, has raised about $2 billion at a valuation of $20 billion, according to a post by Huafeng Capital. Investor Interest and Funding Details The round was led by Chinese food delivery company Meituan's VC arm, Long-Z Investments, with participation from Tsinghua Capital, China Mobile, and CPE Yuanfeng. This recent funding brings Moonshot's total raised to $3.9 billion over the past six months. The Data Analysis Valuation: $20 billion Funding raised: $2 billion Annual recurring revenue: $200 million (as of April) Previous valuation: $4.3 billion (end of 2025), $10 billion (early 2026) The Impact Analysis The fundraising comes as investor appetite for open-weight AI models made by Chinese labs surges. Moonshot's Kimi models have gained significant traction, with the latest model, Kimi K2.6, being the second-most used LLM on distribution platform OpenRouter. The Prediction With demand for open source AI models on the rise, Moonshot AI and its competitors are poised for further growth. Other Chinese AI labs, such as DeepSeek, are reportedly in talks to raise outside capital, while some have even gone public on the back of demand for their AI models.

The Settlement Details Apple has agreed to pay $250 million to settle a class-action lawsuit over how it marketed its AI features ahead of the launch of the iPhone 16. The lawsuit alleged that Apple exaggerated the breadth of features Apple Intelligence would bring, which included a significantly upgraded version of its assistant, Siri. The Allegations Against Apple The complaint alleges that the company created the impression that advanced AI capabilities would be available to users sooner than they actually were. In particular, the plaintiffs allege that Apple overstated both the readiness and functionality of these features, particularly the promised improvements to Siri, which have yet to fully materialize. The Financial Impact Apple will pay up to $250 million to settle the lawsuit. Eligible U.S. customers who purchased the iPhone 15 or iPhone 16 between June 10, 2024, and March 29, 2025, could receive up to $95 per device. The Future of Siri Apple has been touting a more advanced version of Siri ever since it unveiled Apple Intelligence in 2024 during WWDC. The anticipated updates are expected to help Siri function more like modern AI chatbots such as ChatGPT or Claude. The upgraded experience is rumored to be powered by Google Gemini, though newer reports state the company’s next iPhone operating system may let users choose from a number of third-party large language models. The Upcoming Developer Conference The settlement arrives ahead of Apple’s annual developer conference on June 8, when the company is expected to preview a version of its AI-enhanced Siri.

Ethos, a London‑based AI startup, announced a $22.75 million Series A led by a16z on May 6 2026. The round, also backed by General Catalyst, XTX Markets, Evantic Capital, and Common Magic, will accelerate the company’s voice‑powered onboarding system that aims to deliver higher‑quality expert matches for corporate clients. Voice‑Powered Onboarding Redefines Expert Matching Ethos replaces the traditional form‑filled, title‑based profiling used by platforms like LinkedIn, GLG, and AlphaSights with a conversational interview. Experts answer curated questions via voice, allowing the platform to capture nuanced sub‑specializations and real‑world experience that job titles miss. Experts can be queried on complex criteria, e.g., “find people who worked at a funded startup backed by A‑grade investors solving finance automation.” Clients such as hedge funds, private‑equity firms, AI labs, and consulting groups can search across public data (blogs, papers) and voice‑derived insights. Ethos reports roughly 35,000 new experts joining each week, building a deep, searchable talent graph. Funding Round and Valuation Signals The Series A injects $22.75 million into Ethos, bringing its team to eight full‑time members while it scales its data pipeline. Lead investor: a16z (Anish Acharya highlighted voice as “the original form of human communication”). Participating investors: General Catalyst, XTX Markets, Evantic Capital, Common Magic. Revenue model: 30%+ per‑project fee; the company is on track for an eight‑figure annualized revenue run‑rate. Strategic Implications for the Expert‑Network Landscape By capturing richer signals, Ethos challenges legacy platforms that rely on shallow job‑title data. The voice interview approach creates a more granular knowledge graph, aligning with AI labs that are mapping every economically valuable occupation. Potential to attract AI‑driven professional services in law, health, finance, and management. Competitive edge over conversational‑AI interview tools like Listen Labs and Outset, which focus on interview automation rather than expert network depth. Provides a data moat as public sources (blogs, academic papers) are combined with proprietary voice‑derived insights. Growth Trajectory and Market Outlook Ethos aims to keep its core team compact while scaling its expert pool and client base. The influx of capital will support: Expansion of voice‑capture infrastructure and AI matching algorithms. Targeted outreach to high‑value corporate clients and AI research labs. Further integration of external data sources to enrich expert profiles. Analysts expect the voice‑first model to set a new standard for expert networks, especially as enterprises demand more precise skill‑based matches. If Ethos sustains its weekly onboarding rate, the platform could reach a critical mass that forces incumbents to adopt similar AI‑driven profiling methods.

Sudden Passing of a Dual‑Sport LegendThe family of Alex Zanardi confirmed that the former Formula One driver and four‑time Paralympic gold‑medalist died "suddenly" on Friday evening, 2 May 2026. The announcement, made through his charity Obiettivo3, emphasized a peaceful death surrounded by loved ones and requested privacy during the mourning period.From F1 Tracks to Paralympic Podiums: Zanardi’s Remarkable JourneyZanardi began his motorsport career in the early 1990s, racing for Jordan, Minardi and Lotus before moving to the U.S. CART series, where he clinched championships in 1997 and 1998. A catastrophic crash at the Lausitzring in 2001 led to the amputation of both legs, yet he reinvented himself as a hand‑bike athlete, winning gold at the 2012 London and 2016 Rio Paralympic Games.Career Milestones and Accolades in NumbersF1 Grand Prix starts: 84 (1991‑1994, 1999)CART championships: 2 (1997, 1998)Paralympic gold medals: 4 (2012 × 2, 2016 × 2)Major accidents: 2001 (Lausitzring, both legs amputated), 2020 (Tuscany hand‑bike crash)Age at death: 59Legacy Impact on Disability Perception and Italian Sport CulturePrime Minister Giorgia Meloni hailed Zanardi as "a great champion and an extraordinary man," while Cordiano Dagnoni, head of the Italian Cycling Federation, noted that Zanardi "transformed the culture of our country, bringing joy and hope to many." His story reshaped public attitudes toward disability, inspiring policy discussions on accessibility in sport and prompting a minute’s silence at upcoming races.Future of Adaptive Sports and Tribute InitiativesIn the wake of his death, organizers plan memorial rides and scholarships through Obiettivo3 to support emerging para‑athletes. Analysts predict heightened media coverage of adaptive racing categories, potentially accelerating investment in hand‑bike technology and inclusive sporting events across Europe.

The Week's Entertainment Highlights This week offers a diverse range of entertainment options across cinema, music, and art. From highly anticipated film sequels to live performances and immersive exhibitions, there's something for every cultural enthusiast. New Cinema Releases to Watch The entertainment landscape kicks off with several notable film releases. The most anticipated is The Devil Wears Prada 2, which brings back Meryl Streep, Anne Hathaway, and Emily Blunt to their iconic roles. This sequel has been eagerly awaited by fans since the original 2006 film became a cult classic. Other cinematic offerings include Hokum, an Irish haunted-house horror starring Adam Scott (Severance), and Wild Foxes, a French coming-of-age drama that premiered at Cannes last year. Anime enthusiasts can enjoy That Time I Got Reincarnated As a Slime: Tears of the Azure Sea, which bridges the gap between the third and fourth series of the popular Japanese TV show. Live Music Performances Not to Miss The music scene features several notable acts this week. London-based artist Tsatsamis is touring to showcase his mixtape Tsycophant, with tracks like the pensive 'Secret Boyfriend' and the energetic 'Angelina' drawing attention. Tame Impala begins an arena tour in support of their 2023 album Deadbeat, timed perfectly as the album's single 'Dracula' has gone viral on TikTok and gained international chart success following a remix with Blackpink's Jennie. Jazz legend Courtney Pine celebrates four decades in the industry with his 'Out of the Ghetto: A Modern Day Jazz Story' tour, while Glasgow hosts the Tectonics festival, showcasing cutting-edge classical compositions and experimental performances. Art Exhibitions Worth Visiting Art enthusiasts should make time for the Aleksandra Kasuba exhibition at Tate St Ives, running from May 2 to October 4. This marks the first UK show for the Lithuanian American artist, who pioneered immersive art environments long before the genre became mainstream. The exhibition features early paintings, mosaics, and proto-immersive installations exploring utopian ideals of social space.

The Lead The World Health Organization (WHO) has approved the first malaria treatment for babies, marking a significant milestone in the global fight against the disease. Coartem Baby, developed by Novartis and the Medicines for Malaria Venture (MMV), is designed for infants as small as 2kg (4.4lb) and comes in sweet cherry-flavoured tablets that can be dissolved into liquids, including breast milk. The Event Details Coartem Baby contains two antimalarial drugs, artemether and lumefantrine. The treatment has been shown to be safe and effective for newborns and young infants, addressing a critical gap in malaria care. According to the WHO, up to 18% of children under six months in parts of Africa are infected with malaria, but there has historically been no safe treatment for the smallest of them. The Data Analysis Malaria remains a significant public health challenge, particularly in sub-Saharan Africa. In 2024, there were 610,000 deaths from malaria, about three-quarters of which were under-fives in Africa. The approval of Coartem Baby is expected to significantly impact malaria treatment and prevention efforts, particularly in regions with high rates of malaria. The Impact Analysis The introduction of Coartem Baby is a major breakthrough in the fight against malaria. Dr Tedros Adhanom Ghebreyesus, the WHO director general, noted that "for centuries, malaria has stolen children from their parents, and health, wealth and hope from communities." The approval of this treatment offers new hope for communities affected by malaria and brings the global health community closer to achieving its goal of eliminating the disease. The Prediction With the WHO prequalification of Coartem Baby, public-sector procurement of the treatment is expected to increase in many countries with high rates of malaria, particularly in sub-Saharan Africa. Novartis has committed to making the treatment available "on a largely not-for-profit basis in malaria-endemic regions." As more countries introduce Coartem Baby into their health systems, the impact on malaria-related mortality and morbidity is expected to be significant.

The Marathon Match that Defined the WeekendLeeds Rhinos demonstrated remarkable resilience in a bruising encounter against Wakefield Trinity, securing a win that extends their unbeaten run. The match, which lasted well over two hours, was marred by a serious head injury to Wakefield's Cameron Scott, necessitating a lengthy stoppage in the early stages. Despite being reduced to 12 men on the field at various points due to sin-bins for Sivo and Ash Handley, Leeds held firm.Maika Sivo's Historic Scoring RateFijian winger Maika Sivo delivered a performance of sheer dominance, claiming a hat-trick that brings his season tally to 17 tries in just nine Super League games. His clinical finishing was the difference maker, with half-back Jake Connor providing the service. Sivo's efficiency places him among the elite goal-kickers of the modern era, making him a focal point of Leeds' attacking strategy.Connor's Case for England: A World Cup StatementWhile Sivo grabbed the headlines, Jake Connor's influence was equally pivotal. Providing four try assists, Connor orchestrated Leeds' attack with precision. His performance serves as a powerful rebuttal to his omission from last year's Ashes series, putting immense pressure on new England coach Brian McDermott to select him as the starting scrum-half for the Rugby League World Cup.Leeds Rhinos: The Title Contenders' ResilienceBrad Arthur's side has now won 8 of their last 10 games, keeping them ahead of St Helens on points difference. The victory underscores a growing trend: Leeds is not just winning, but winning ugly when necessary. Their ability to withstand Wakefield's fightback and maintain composure under pressure suggests they are the team to beat in the current Super League season.